<DOC>
	<DOCNO>NCT00209573</DOCNO>
	<brief_summary>This study design demonstrate AQUAVAN® effective provide adequate sedation patient undergo colonoscopy well assess safety profile AQUAVAN versus midazolam . Prior procedure , patient receive fentanyl citrate pain management follow five minute later AQUAVAN® Injection sedation . Throughout procedure , study personnel assess patient 's vital sign depth sedation . After procedure , patient , physician , evaluator ask complete satisfaction survey .</brief_summary>
	<brief_title>A Study AQUAVAN® Injection Versus Midazolam HCl Sedation Patients Undergoing Elective Colonoscopy</brief_title>
	<detailed_description>This randomize , open-label study design ass safety efficacy AQUAVAN® Injection versus midazolam HCl follow pretreatment analgesic , fentanyl citrate injection , produce sedation patient undergoing colonoscopy . Randomization stratify site . Following completion pre-procedure sedation assessment , patient randomly assign 1 2 i.v . treatment group 3:1 ( AQUAVAN® Injection : midazolam HCl ) allocation ratio . All study patient , irrespective treatment group assignment , receive fentanyl citrate injection analgesic pretreatment . Supplemental dos fentanyl citrate injection may administer patient report pain inadequate analgesia present demonstrate increased heart rate and/or blood pressure presence adequate sedation . At time fentanyl citrate injection administer increase sedation level . AQUAVAN® Injection midazolam HCl administer induce state adequate sedation , define Modified Observer 's Assessment Alertness / Sedation ( OAA/S ) score 4 less . Supplemental dos administer increase depth duration sedation . Supplemental dos administer Modified OAA/S score 2 less purposeful response stimulation . The depth sedation measure Modified OAA/S scale , validated measure . Patient Investigator assessment use confirm depth sedation provide met goal sedation , reduction anxiet , reduce awareness .</detailed_description>
	<mesh_term>Fospropofol</mesh_term>
	<mesh_term>Midazolam</mesh_term>
	<criteria>Patient provide signed/dated Informed Consent HIPAA authorization receive full explanation extent nature study ; Patient , female , surgically sterile , postmenopausal nonpregnant non lactate use acceptable method birth control least 1 month prior dose , negative urine pregnancy test result screen predose period ; Patient meet American Society Anesthesiologists ( ASA ) Physical Status Classification System I III . Patient history allergic reaction hypersensitivity anesthetic agent , narcotic , benzodiazepine ; Patient meet nil per o ( NPO ) status per ASA Guideline institution 's guideline . Patient condition ( ) , opinion Investigator , could interfere appropriate airway management ; Patient participate investigational drug study within 1 month prior study start ; Patient history mental visual impairment would permit successful measurement cognitive evaluation ; Patient unwilling adhere pre postprocedural instruction ; Patient use fentanyl midazolam contraindicate .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>November 2008</verification_date>
	<keyword>Colonoscopy</keyword>
	<keyword>Sedation</keyword>
</DOC>